Autor: |
te Raa GD; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Moerland PD; Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands., Leeksma AC; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Derks IA; Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Yigittop H; MRC-Holland, Amsterdam, The Netherlands., Laddach N; MRC-Holland, Amsterdam, The Netherlands., Loden-van Straaten M; MRC-Holland, Amsterdam, The Netherlands., Navrkalova V; Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Trbusek M; Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Luijks DM; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Zenz T; Department of Translational Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ) and Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Skowronska A; School of Cancer Sciences, University of Birmingham, Birmingham, UK., Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Stankovic T; School of Cancer Sciences, University of Birmingham, Birmingham, UK., van Oers MH; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] LYMMCARE (Lymphoma and Myeloma Center), Amsterdam, The Netherlands., Eldering E; 1] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands [2] LYMMCARE (Lymphoma and Myeloma Center), Amsterdam, The Netherlands., Kater AP; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands [3] LYMMCARE (Lymphoma and Myeloma Center), Amsterdam, The Netherlands. |